These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28859268)

  • 41. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.
    Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M
    Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
    Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K
    J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.
    Moustafa D; Garg VK; Jain N; Sriranganathan N; Vemulapalli R
    Vaccine; 2011 Jan; 29(4):784-94. PubMed ID: 21109033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
    de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
    Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51.
    Vemulapalli R; He Y; Cravero S; Sriranganathan N; Boyle SM; Schurig GG
    Infect Immun; 2000 Jun; 68(6):3286-9. PubMed ID: 10816475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accidental exposure to Brucella abortus vaccines and occupational brucellosis among veterinarians in Minas Gerais state, Brazil.
    Pereira CR; de Oliveira IRC; de Oliveira LF; de Oliveira CSF; Lage AP; Dorneles EMS
    Transbound Emerg Dis; 2021 May; 68(3):1363-1376. PubMed ID: 32810924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.
    Dorneles EM; Lima GK; Teixeira-Carvalho A; Araújo MS; Martins-Filho OA; Sriranganathan N; Al Qublan H; Heinemann MB; Lage AP
    PLoS One; 2015; 10(9):e0136696. PubMed ID: 26352261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
    Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rough Brucella neotomae provides protection against Brucella suis challenge in mice.
    Jain-Gupta N; Waldrop SG; Tenpenny NM; Witonsky SG; Boyle SM; Sriranganathan N
    Vet Microbiol; 2019 Dec; 239():108447. PubMed ID: 31767087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
    Hamdy ME; El-Gibaly SM; Montasser AM
    Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis.
    Zhao WR; Wendoso ; Hasi ; Qin YX; Weng W; Lu SL
    J Med Microbiol; 1989 Oct; 30(2):143-8. PubMed ID: 2795638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of novel drug targets for humans and potential vaccine targets for cattle by subtractive genomic analysis of Brucella abortus strain 2308.
    Mahmud A; Khan MT; Iqbal A
    Microb Pathog; 2019 Dec; 137():103731. PubMed ID: 31509762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermostable cross-protective subunit vaccine against Brucella species.
    Cherwonogrodzky JW; Barabé ND; Grigat ML; Lee WE; Poirier RT; Jager SJ; Berger BJ
    Clin Vaccine Immunol; 2014 Dec; 21(12):1681-8. PubMed ID: 25320267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.